Case Study:
Customized Biocatalysts
Case Study:
Pharmaceutical Intermediates
Latest News
- January 29, 2008
Codexis Launches Codex™ Microcyp Platform To Produce Drug Metabolites And Novel Lead Compounds - January 17, 2008
Codexis Names Nicholas Green President, Codexis Pharmaceuticals - October 25, 2007
Codexis Opens Singapore Laboratory - October 1, 2007
Codexis Announces Four New Codex™ Biocatalyst Panels
Making Greener Products, with Smarter Technology
Codexis Pharma Services develops customized biocatalysts Close
Biocatalyst or Biological CatalystA catalyst derived from a living organism. Enzymes and fermentation strains are common biocatalysts. Biocatalysts significantly speed chemical reactions.and intermediates for the manufacture of innovative pharmaceutical compounds. Customized biocatalysts are created using Codexis proprietary technology, and are used to facilitate the production of pharmaceutical intermediates. Our customized biocatalysts and intermediates make it possible for our customers to shorten process development timelines, increase product purity profiles, and reduce manufacturing time, cost and waste. In 2007, Codexis acquired BioCatalytics, giving Codexis customers access to the BioCatalytics portfolio of enzymes and metabolite production and screening products and services.
Customer Focused
Pharmaceutical companies depend on product quality and rapid time to market. At Codexis Pharma Services, we meet those needs with research and development and manufacturing operations that are focused on customer priorities.
Download Product List
Codexis now offers a selection of proprietary biocatalysts for research purposes.Download our full product listing
Adobe Acrobat required
Quick Search
Search for product
Enter any of the following options in the search area. You may search by chemical name, order number, CAS number, or molecular formula.
Examples:
- complete chemical name: N-Acetylneuraminic acidfree acid
- partial name: acetyl
- CAS Number: 131-48-6
- molecular formula: C11H19NO9